Pasura Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 9.49 M
as on 17-07-2024
- Company Age 22 Year, 8 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 41.80 Cr
as on 17-07-2024
- Satisfied Charges ₹ 1.80 Cr
as on 17-07-2024
- Revenue %
(FY 2021)
- Ebitda
- Net Worth -1.54%
(FY 2021)
- Total Assets -11.39%
(FY 2021)
About Pasura Life Sciences
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.49 M.
The company currently has active open charges totaling ₹41.80 Cr. The company has closed loans amounting to ₹1.80 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pabbathi Kumar and Satyanarayana Pabbathi serve as directors at the Company.
- CIN/LLPIN
U24239TG2002PTC038762
- Company No.
038762
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Apr 2002
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medchal Mandal, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pasura Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pabbathi Kumar  | Director | 01-Oct-2014 | Current |
| Satyanarayana Pabbathi | Director | 01-Oct-2014 | Current |
Financial Performance of Pasura Life Sciences.
Pasura Life Sciences Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 1.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Pasura Life Sciences?
In 2021, Pasura Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pasura Genetix Private LimitedActive 27 years 6 monthsPabbathi Kumar and Satyanarayana Pabbathi are mutual person
- Papillon Market Innovators Private LimitedActive 19 years 11 months
Satyanarayana Pabbathi is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Nov 2010 | ₹1.80 Cr | Open |
State Bank Of Hyderabad Creation Date: 11 Jul 2007 | ₹30.00 Cr | Open |
State Bank Of Hyderabad Creation Date: 04 Aug 2006 | ₹10.00 Cr | Open |
How Many Employees Work at Pasura Life Sciences?
Unlock and access historical data on people associated with Pasura Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pasura Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pasura Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
